Literature DB >> 20814684

[Canaloplasty. A new way in glaucoma surgery?].

N Körber1.   

Abstract

Evaluation of the surgical treatment of open angle glaucoma depends on values, such as target pressure, success rates and complication rates. Canaloplasty is a new non-penetrating method for glaucoma surgery and the aim of this article is to present the surgical approach, indications, results and post-operative therapy. During the operation a viscocanalostomy according to Robert Stegmann is performed. Subsequently a microcatheter with an outer diameter of 200 μ is used to circumferentially dilate Schlemm's canal. During the dilation microvolumes of a high viscosity ophthalmic viscosurgical device (OVD) (sodium hyaluronate) are injected. After successful dilation the catheter is retracted and at the same time a 10.0 Prolene suture is placed in the canal and closed tightly to apply permanent tension to the trabecular meshwork.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20814684     DOI: 10.1007/s00347-010-2234-4

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  15 in total

1.  Viscocanalostomy for open-angle glaucoma in black African patients.

Authors:  R Stegmann; A Pienaar; D Miller
Journal:  J Cataract Refract Surg       Date:  1999-03       Impact factor: 3.351

2.  Primary viscocanalostomy versus trabeculectomy for primary open-angle glaucoma: three-year prospective randomized clinical trial.

Authors:  Ilgaz Sagdic Yalvac; Mehmet Sahin; Umit Eksioglu; Inci Kocak Midillioglu; Bekir Sitki Aslan; Sunay Duman
Journal:  J Cataract Refract Surg       Date:  2004-10       Impact factor: 3.351

3.  Microsurgery of Schlemm's canal and the human aqueous outflow system.

Authors:  M A Johnstone; W M Grant
Journal:  Am J Ophthalmol       Date:  1973-12       Impact factor: 5.258

4.  The National Survey of Trabeculectomy. III. Early and late complications.

Authors:  B Edmunds; J R Thompson; J F Salmon; R P Wormald
Journal:  Eye (Lond)       Date:  2002-05       Impact factor: 3.775

5.  The Advanced Glaucoma Intervention Study: 8. Risk of cataract formation after trabeculectomy.

Authors: 
Journal:  Arch Ophthalmol       Date:  2001-12

6.  Deep sclerectomy versus punch trabeculectomy: effect of low-dosage mitomycin C.

Authors:  Salvatore Cillino; Francesco Di Pace; Alessandra Casuccio; Gaetano Lodato
Journal:  Ophthalmologica       Date:  2005 Sep-Oct       Impact factor: 3.250

7.  Channelography: imaging of the aqueous outflow pathway with flexible microcatheter and fluorescein in canaloplasty.

Authors:  M C Grieshaber; A Pienaar; J Olivier; R Stegmann
Journal:  Klin Monbl Augenheilkd       Date:  2009-04-21       Impact factor: 0.700

8.  Canaloplasty: circumferential viscodilation and tensioning of Schlemm canal using a flexible microcatheter for the treatment of open-angle glaucoma in adults: two-year interim clinical study results.

Authors:  Richard A Lewis; Kurt von Wolff; Manfred Tetz; Norbert Koerber; John R Kearney; Bradford J Shingleton; Thomas W Samuelson
Journal:  J Cataract Refract Surg       Date:  2009-05       Impact factor: 3.351

9.  Efficacy and safety of mitomycin-C in primary trabeculectomy: five-year follow-up.

Authors:  Rajiv Bindlish; Garry P Condon; James D Schlosser; Joyce D'Antonio; Karen B Lauer; Richard Lehrer
Journal:  Ophthalmology       Date:  2002-07       Impact factor: 12.079

10.  Viscocanalostomy versus trabeculectomy in white adults affected by open-angle glaucoma: a 2-year randomized, controlled trial.

Authors:  Roberto G Carassa; Paolo Bettin; Marina Fiori; Rosario Brancato
Journal:  Ophthalmology       Date:  2003-05       Impact factor: 12.079

View more
  2 in total

1.  [Canaloplasty after trabeculectomy].

Authors:  N Körber
Journal:  Ophthalmologe       Date:  2015-04       Impact factor: 1.059

2.  Intracorneal blood removal six weeks after canaloplasty.

Authors:  Alberto Rossetti; Norbert Koerber; Daniele Doro
Journal:  Indian J Ophthalmol       Date:  2013-05       Impact factor: 1.848

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.